Search Results - "Jager, U"

High-throughput miRNA profiling of human melanoma blood samples by Leidinger, Petra, Keller, Andreas, Borries, Anne, Reichrath, Jörg, Rass, Knuth, Jager, Sven U, Lenhof, Hans-Peter, Meese, Eckart

“…MicroRNA (miRNA) signatures are not only found in cancer tissue but also in blood of cancer patients. Specifically, miRNA detection in blood offers the…”
Get full text

TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) by Morschhauser, F., Dahiya, S., Palomba, M. L., Garcia‐Sancho, A. M., Ortega, J. L. Reguera, Kuruvilla, J., Jager, U., Cartron, G., Izutsu, K., Dreyling, M., Kahl, B., Ghesquieres, H., Ardeshna, K., Goto, H., Barbui, A. M., Abramson, J. S., Borchmann, P., Fleury, I., Mielke, S., Farazi, T., Fasan, O., Lymp, J., Vedal, M., Nishii, R., Avilion, A., Papuga, J., Nastoupil, L. J.

Get full text

CHOP-21 for the treatment of post-transplant lymphoproliferative disorders following solid organ transplantation by Choquet, Sylvain, Trappe, Ralf, Leblond, Veronique, Jager, Ulrich, Davi, Frederic, Oertel, Stephan

“…* Department of Haematology, Hôpital Pitié-Salpétrière, Paris, France ° Department of Hematology and Oncology, Charité, Universitätsmedizin Berlin, Campus…”
Get full text

20% Efficient Passivated Large-Area Metal Wrap Through Solar Cells on Boron-Doped Cz Silicon by Lohmuller, E., Thaidigsmann, B., Pospischil, M., Jager, U., Mack, S., Specht, J., Nekarda, J., Retzlaff, M., Krieg, A., Clement, F., Wolf, A., Biro, D., Preu, R.

“…We present metal wrap through passivated emitter and rear solar cells (MWT-PERC) on monocrystalline p-type silicon featuring laser-doped selective emitter…”
Get full text

Autoimmune thrombocytopenia in non-Hodgkin's lymphomas by Hauswirth, Alexander W, Skrabs, Cathrin, Schutzinger, Christian, Raderer, Markus, Chott, Andreas, Valent, Peter, Lechner, Klaus, Jager, Ulrich

“…1 Department of Medicine I, Division of Hematology and Hemostaseology and 2 Oncology 3 Department of Pathology, Medical University of Vienna, Vienna, Austria…”
Get full text

Comprehensive Microscopic Analysis of Laser-Induced High Doping Regions in Silicon by Gundel, P., Suwito, D., Jager, U., Heinz, F. D., Warta, W., Schubert, M. C.

“…Microscopic laser-doped regions in advanced solar cell concepts are analyzed to determine the doping density and to identify the damage caused by the laser…”
Get full text

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial by Hallek, M, Prof, Fischer, K, MD, Fingerle-Rowson, G, MD, Fink, AM, MD, Busch, R, Mayer, J, Prof, Hensel, M, Prof, Hopfinger, G, MD, Hess, G, MD, von Grünhagen, U, MD, Bergmann, M, MD, Catalano, J, MD, Zinzani, PL, Prof, Caligaris-Cappio, F, Prof, Seymour, JF, Prof, Berrebi, A, Prof, Jäger, U, Prof, Cazin, B, MD, Trneny, M, MD, Westermann, A, Wendtner, CM, Prof, Eichhorst, BF, MD, Staib, P, MD, Bühler, A, MD, Winkler, D, MD, Zenz, T, MD, Böttcher, S, MD, Ritgen, M, MD, Mendila, M, MD, Kneba, M, Prof, Döhner, H, Prof, Stilgenbauer, S, Prof

“…Summary Background On the basis of promising results that were reported in several phase 2 trials, we investigated whether the addition of the monoclonal…”
Get full text

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) by Hayden, P.J., Roddie, C., Bader, P., Basak, G.W., Bonig, H., Bonini, C., Chabannon, C., Ciceri, F., Corbacioglu, S., Ellard, R., Sanchez-Guijo, F., Jäger, U., Hildebrandt, M., Hudecek, M., Kersten, M.J., Köhl, U., Kuball, J., Mielke, S., Mohty, M., Murray, J., Nagler, A., Rees, J., Rioufol, C., Saccardi, R., Snowden, J.A., Styczynski, J., Subklewe, M., Thieblemont, C., Topp, M., Ispizua, Á.U., Chen, D., Vrhovac, R., Gribben, J.G., Kröger, N., Einsele, H., Yakoub-Agha, I.

“…Several commercial and academic autologous chimeric antigen receptor T-cell (CAR-T) products targeting CD19 have been approved in Europe for…”
Get full text

H-Net, the European Network for Harmonization of Training in Hematology, and its policy by de Wit, Thom Duyvené, Hellström-Lindberg, Eva, Jäger, Ulrich, Evans-Jones, Gareth, Smand, Carin

Get full text

Bendamustine is Safe and Effective for Lymphodepletion Before Tisagenlecleucel in Patients with Refractory or Relapsed Large B-Cell Lymphomas by Ghilardi, G., Chong, E.A., Svoboda, J., Wohlfarth, P., Nasta, S.D., Williamson, S., Landsburg, J.D., Gerson, J.N., Barta, S.K., Pajarillo, R., Myers, J., Chen, A.I., Schachter, L., Yelton, R., Ballard, H.J., Hodges Dwinal, A., Gier, S., Victoriano, D., Weber, E., Napier, E., Garfall, A., Porter, D.L., Jäger, U., Maziarz, R.T., Ruella, M., Schuster, S.J.

“…Anti-CD19 chimeric antigen receptor T-cell immunotherapy (CAR-T) is now a standard treatment for relapsed or refractory B-cell non-Hodgkin lymphomas; however,…”
Get full text

Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition by Köhrer, S, Havranek, O, Seyfried, F, Hurtz, C, Coffey, G P, Kim, E, ten Hacken, E, Jäger, U, Vanura, K, O'Brien, S, Thomas, D A, Kantarjian, H, Ghosh, D, Wang, Z, Zhang, M, Ma, W, Jumaa, H, Debatin, K-M, Müschen, M, Meyer, L H, Davis, R E, Burger, J A

“…Precursor-B-cell receptor (pre-BCR) signaling and spleen tyrosine kinase (SYK) recently were introduced as therapeutic targets for patients with B-cell acute…”
Get full text

Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia by Skrabs, C., Pickl, W. F., Perkmann, T., Jäger, U., Gessl, A.

“…Summary What is known and objective Ibrutinib is inhibiting the Bruton's tyrosine kinase (BTK), thereby influencing B‐cell development. We describe an…”
Get full text

Waldenstrom's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Buske, C, Leblond, V, Dimopoulos, M, Kimby, E, Jäger, U, Dreyling, M

Get full text

Multiple myeloma : high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization by DRACH, J, SCHUSTER, J, LECHNER, K, LUDWIG, H, HUBER, H, NOWOTNY, H, ANGERLER, J, ROSENTHAL, F, FIEGL, M, ROTHERMUNDT, C, GSUR, A, JÄGER, U, HEINZ, R

“…Because metaphase cytogenetic studies in multiple myeloma (MM) are hampered by a low proliferative activity of myeloma cells in vitro, interphase cytogenetics…”
Get full text

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0 by Kiesewetter, B., Dafni, U., de Vries, E.G.E., Barriuso, J., Curigliano, G., González-Calle, V., Galotti, M., Gyawali, B., Huntly, B.J.P., Jäger, U., Latino, N.J., Malcovati, L., Oosting, S.F., Ossenkoppele, G., Piccart, M., Raderer, M., Scarfò, L., Trapani, D., Zielinski, C.C., Wester, R., Zygoura, P., Macintyre, E., Cherny, N.I.

“…The European Society for Medical Oncology (ESMO)-Magnitude of Clinical Benefit Scale (MCBS) has been accepted as a robust tool to evaluate the magnitude of…”
Get full text

A Comprehensive Analysis of the Cellular and EBV‐Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV‐Associated Tumors by Fink, S. E. K., Gandhi, M. K., Nourse, J. P., Keane, C., Jones, K., Crooks, P., Jöhrens, K., Korfel, A., Schmidt, H., Neumann, S., Tiede, A., Jäger, U., Dührsen, U., Neuhaus, R., Dreyling, M., Borchert, K., Südhoff, T., Riess, H., Anagnostopoulos, I., Trappe, R. U.

“…Primary central nervous system (pCNS) posttransplant lymphoproliferative disorder (PTLD) is a complication of solid organ transplantation characterized by poor…”
Get full text

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group by Hoechstetter, M A, Busch, R, Eichhorst, B, Bühler, A, Winkler, D, Eckart, M J, Vehling-Kaiser, U, Schimke, H, Jäger, U, Hurtz, H J, Hopfinger, G, Hartmann, F, Fuss, H, Abenhardt, W, Blau, I, Freier, W, Müller, L, Goebeler, M, Wendtner, C M, Bahlo, J, Fischer, K, Bentz, M, Emmerich, B, Döhner, H, Hallek, M, Stilgenbauer, S

Get full text

Innovative strategies in lymphoma therapy by Jäger, Ulrich

“…Treatment of malignant non-Hodgkin lymphomas (NHL) in the 21st century has been revolutionized by novel biological agents offering targeted approaches in…”
Get full text

Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study by Morschhauser, Franck, Dahiya, Saurabh, Palomba, M. Lia, Martin Garcia-Sancho, Alejandro, Reguera Ortega, Juan Luis, Kuruvilla, John, Jäger, Ulrich, Cartron, Guillaume, Izutsu, Koji, Dreyling, Martin, Kahl, Brad, Ghesquieres, Hervé, Ardeshna, Kirit, Goto, Hideki, Barbui, Anna Maria, Abramson, Jeremy S., Borchmann, Peter, Fleury, Isabelle, Mielke, Stephan, Skarbnik, Alan, de Vos, Sven, Kamdar, Manali, Karmali, Reem, Viardot, Andreas, Farazi, Thalia, Fasan, Omotayo, Lymp, James, Vedal, Min, Nishii, Rina, Avilion, Ariel, Papuga, Jessica, Kumar, Jinender, Nastoupil, Loretta J.

Get full text

Interphase Fluorescence In Situ Hybridization Identifies Chromosomal Abnormalities in Plasma Cells From Patients With Monoclonal Gammopathy of Undetermined Significance by Drach, Johannes, Angerler, Jutta, Schuster, Judith, Rothermundt, Christian, Thalhammer, Renate, Haas, Oskar A., Jäger, Ulrich, Fiegl, Michael, Geissler, Klaus, Ludwig, Heinz, Huber, Heinz

“…Karyotypic studies in patients with monoclonal gammopathy of undetermined significance (MGUS) have been hampered by a low percentage of bone marrow plasma…”
Get full text